Unbiased AI-powered news
2 stories related to this topic, newest first.
U.S. senators are reviving a proposal to extend the $35 insulin price cap beyond Medicare to the private market and uninsured patients. The measure is modeled on a 2022 law that already limits costs for Medicare beneficiaries.
Substrate placeholder — needs reviewA pharmaceutical company has introduced insulin at a $35 monthly price cap for certain patients. Studies provide additional evidence on the safety of abortion medications for over-the-counter use. These updates form part of broader health news coverage.